San Francisco startup Framework Therapeutics is additionally focusing on an oral, when-every day GLP-one drug known as GSBR-1290—the drug surpassed Wall Road’s anticipations in June when a mid-phase examine showed average weight loss of all over six% and it designs to start out A fur